Dietary starch and glycogen

Dietary starch and glycogen are complex polysaccharides that serve as the primary source of glucose in the human diet (StatPearls, 2023). In the intestinal lumen, these molecules are broken down into smaller oligosaccharides and eventually monosaccharides by the action of salivary and pancreatic alpha-amylase and brush-border alpha-glucosidases, such as maltase-glucoamylase and sucrase-isomaltase (Reactome, 2022). While starch and glycogen are substrates rather than therapeutic targets, the enzymes that catalyze their digestion are major targets for pharmacological intervention in metabolic diseases (PubMed, 2021). Drugs such as acarbose and miglitol competitively inhibit these enzymes to slow carbohydrate absorption and mitigate postprandial glucose spikes (PubChem, 2024). This mechanism is particularly beneficial for managing type 2 diabetes and may play a role in weight management (NIH, 2023). However, the presence of undigested starch in the large intestine can lead to bacterial fermentation, causing common side effects like flatulence and diarrhea (Mayo Clinic, 2023). The rate of digestion of these carbohydrates is a key determinant of the glycemic index of foods, which is a critical factor in dietary management of metabolic syndrome. Therapeutic strategies often focus on modulating the activity of the enzymes involved in this process to improve metabolic health.

Other names

StarchGlycogenAmyloseAmylopectinComplex carbohydrates

Inhibition of alpha-amylase and alpha-glucosidase enzymes to delay the hydrolysis of starch and glycogen into glucose